In another study, AQP3 was shown to be overexpressed in non-small carcinoma (NSCLC), particularly adenocarcinomas, as well as well-differentiated bronchioloalveolar carcinomas and papillary subtypes. Here, AQP3 is linked to non-small cell lung carcinoma.